August 2013 - Page 16 of 18

MondayAug 05, 2013 11:47 am

VistaGen Therapeutics, Inc. (VSTA) Aims to Revive Once-Promising Drug Candidates with Latest Medicinal Technology

VistaGen is a biotech company applying human pluripotent stem cell technology for drug rescue and regenerative cell therapy. The company’s drug rescue program involves combining this stem cell technology with the latest medicinal chemistry to create new chemical variants of once-promising small molecule drug candidates that were discontinued prior to market approval due to unexpected safety concerns of the heart and/or liver. VSTA is primarily focused on leveraging its Human Clinical Trials in a Test Tube™ platform to assess heart and liver toxicity of new drug candidates in an accelerated and higher precision means versus currently used in vitro techniques…

MondayAug 05, 2013 11:14 am

NanoTech Entertainment, Inc. (NTEK) Further Reduces Share Count, Boosts Shareholder Value

NanoTech Entertainment just announced that it has completed the third phase of an ongoing plan to decrease the number of outstanding shares. The NanoTech Board of Directors had previously authorized a program under which the company has already retired 221 million shares of its outstanding common stock. At the 2013 shareholders meeting Director Ted Campbell announced a continuation of the effort. Campbell stated, “Early on, NanoTech had leveraged its ability to finance the company through a series of convertible debentures. Now that we have moved out of the R&D phase and have several products gaining traction in the market, we…

MondayAug 05, 2013 8:52 am

Aradigm Corp. (ARDM) Receives NIH Grant to Study Pulmaquin, Lipoquin as Treatment of Pulmonary Non-Tuberculosis Mycobacterial Infections

Aradigm, a specialty pharmaceutical company focused on developing and commercializing a portfolio of drugs for the treatment of severe respiratory diseases, has been awarded a Small Business Initiative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH). The $278,000 grant was awarded to assist Aradigm in the investigation of the treatment of pulmonary non-tuberculous mycobacteria (PNTM) infections with the company’s inhaled liposomal ciprofloxacin products, Pulmaquin® and Lipoquin®. The principal investigator is Dr. James D. Blanchard, principal scientist of Preclinical Development at Aradigm. Dr. Luiz Bermudez at the Oregon State University, Corvallis,…

MondayAug 05, 2013 8:49 am

Eco Building Products, Inc. (ECOB) Announces Opening of Additional Coating Facility in New Jersey

Eco Building Products, a manufacturer of treated wood products that are protected against fire, mold/mycotoxins, fungus, rot-decay, wood ingesting insects, and termites, Friday announced that it has established Eco Red Shield lumber coating services in Fairlawn, New Jersey. The location is slated to open its doors in August 2013, equipped with rail service and lumber yard. The announcement of the new facility arrives on the heels of Eco's fledgling Sandy Rebuild, further fueled by the Governor of New Jersey's administration issuing mold mitigation guidance targeting residential recovery efforts from last year's super storm Sandy. In an effort to show continued…

MondayAug 05, 2013 8:43 am

Music that Matters Selects NanoTech Entertainment, Inc. (NTEK) to Launch IPTV/OTT Music Channel

Music that Matters recently announced that it has chosen NanoTech Entertainment to provide the technology and backbone for its upcoming IPTV/OTT music channel. In recent years Music that Matters has successfully raised thousands of dollars through benefit concerts for social and environmental causes, working in collaboration with top music artists. The non-profit has announced plans to launch its IPTV anywhere and Roku video music channel on the NanoFlix network, on August 5, 2013. The channel is set to initially feature two pay-per-view benefit concerts. The first feature, Bob Weir and Tim Flannery, Live from the Uptown Theatre is a benefit…

MondayAug 05, 2013 8:35 am

Solar Wind Energy Tower, Inc. (SWET) Applies for New Patent to Protect Efficiency-Enhancing Innovations

Solar Wind Energy Tower, the inventor of a large Solar Wind Downdraft Tower structure capable of producing abundant, inexpensive electricity, today told investors of a new patent application titled "Atmospheric Energy Extraction Devices and Methods." This application was filed with request for prioritized examination. The objectives of the new patent application are significant. Incorporated into the existing core design, for which a patent has already been issued to SWET, are a variety of innovative improvements that will increase the efficiency to construct the Tower and enhance the Tower's operational capabilities. The original Tower structure was tubular in shape and concentric…

FridayAug 02, 2013 1:06 pm

All Grade Mining, Inc. (HYII) is “One to Watch”

All Grade Mining is primarily focused on developing the Saltirosa iron mine in the Republic of Chile. Located 28 kilometers from Chanaral, the mine is comprised of an updated 741 hectares spanning 24 square kilometers with an estimated iron ore reserve of over 40 million metric tons based on magnometric and geological studies done on the property. The necessary professionals required for site planning, excavation engineering, material sampling, concentration methodology, environmental impact declaration, and logistics have been hired. All Grade Mining expects to bring production up to 150,000 Metric Tons monthly, which would generate revenues of approximately $21 million based…

FridayAug 02, 2013 12:02 pm

Max Sound Corp. (MAXD) Changing the Tune of High Definition Music

Max Sound is a high-definition (HD) audio company focused on enhancing the quality of sound in music, movies, audiobooks, video games, television, live events, and mobile devices with its patent pending MAX-D HD technology. MAX-D’s technology works by polishing the conversion process called “compression,” which is the process in which music is convened into smaller files (MP3) so hundreds of songs will fit on devices such as smartphones and MP3 players. Compressing these files can sacrifice the quality of music, and this is what MAX-D aims to fix. In late 2012, MAX-D acquired music download site Liquid Spins to assist…

FridayAug 02, 2013 11:49 am

Rafarma Pharmaceuticals, Inc. (RAFA) Triggers Growth in Russian Economic Development Region, Subsequent Partnership Opportunity

The strategic selection of Terbuny, Russia, as the home for Rafarma Pharmaceuticals’ world-class manufacturing facility has resulted in more biotech companies moving into the area, and has already provided Rafarma with specialized collaboration opportunities. A newly announced facility specifically devoted to dialysis research and product development will be located near Rafarma's pharmaceutical plant in Terbuny in the Lipetsk region of Russia, located just a few hours south from Moscow. Rafarma and the new dialysis facility intend to work together to develop dialysis-specific products. “Rafarma was one of the first to build and operate in Terbuny, and the company's success looks…

FridayAug 02, 2013 11:01 am

MELA Sciences, Inc. (MELA) Video Chart for Friday, August 2, 2013

MELA made a nice move off a bottom of 70 cent in June to a high of $1.07 in July. The stock price has retraced to form a support at 88 cents. An increase in volume and rise in share value on Thursday has the chart on watch to try and break through the 50-day moving average to continue an overall reversal of the chart. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts Let us hear your thoughts below:

Site Search

Company Search

Month: August 2013